Brian J. Mehigan - Publications

Circulating Tumour DNA After Neoadjuvant Therapy in Non-Metastatic Colon Cancer: A Systematic Review and Implications for Surgical Decision-Making.

Journal: Cancers

Published: January 13, 2026

A multi-omic biomarker signature in pre-treatment rectal tumours stratifies patients with different pathological responses to neoadjuvant treatment.

Journal: Clinical and translational medicine

Published: October 23, 2025

Outcomes Following Colorectal Cancer Resection in Elderly Patients.

Journal: Current oncology (Toronto, Ont.)

Published: October 16, 2025

The use of negative pressure wound therapy following stoma reversal: a systematic review and meta-analysis of randomized controlled trials.

Journal: International journal of colorectal disease

Published: March 12, 2025

Immunotherapy for downstaging of locally advanced mismatch repair deficient colorectal cancer: A prospective institutional case series.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: March 01, 2025

MRI-based radiomics nomogram to predict complete response to definitive chemoradiation in patients with anal cancer.

Journal: The British journal of radiology

Published: January 14, 2025

Factors Influencing Outcomes and Survival in Anal Cancer.

Journal: Current oncology (Toronto, Ont.)

Published: July 21, 2024

The Optimal Approach to Surgical Management of Goblet Cell Carcinoid of the Appendix: A Systematic Review.

Journal: Diagnostics (Basel, Switzerland)

Published: June 17, 2024

Assessing circulating tumour DNA (ctDNA) as a prognostic biomarker in locally advanced rectal cancer: a systematic review and meta-analysis.

Journal: International journal of colorectal disease

Published: May 23, 2024

Robotic transanal minimally invasive surgery (R-TAMIS): current evidence in the treatment of early rectal neoplasia.

Journal: International journal of colorectal disease

Published: May 02, 2024

Complement is increased in treatment resistant rectal cancer and modulates radioresistance.

Journal: Cancer letters

Published: April 10, 2024

Assessing Circulating Tumour DNA (ctDNA) as a Biomarker for Anal Cancer Management: A Systematic Review.

Journal: International journal of molecular sciences

Published: February 21, 2024